Mutants resistant to dihydrostreptomycin were isolated and genetically analyzed in Bacillus subtilis. Two new classes of mutants distinct from the ribosomal strA locus were found. One class, strB, was located between metC3 and ura-1 on the chromosome. The second class, strC, mapped in the spore gene region close to the spoA locus. Both mutant classes were resistant to dihydrostreptomycin during growth but sensitive to the antibiotic during sporulation. Resuspension sporulation experiments with a strB mutant showed that sensitivity to the antibiotic was acquired early in the sporulation process. The germination and outgrowth of strB spores was sensitive to the antibiotic until growth commenced, whereupon the culture was resistant. Thus the mutants are sensitive to dihydrostreptomycin during both sporulation and germination but resistant during the growth phase.
Resistance to the aminoglycoside antibiotic, streptomycin (SM), has been extensively studied in various microorganisms over the last decade. In Escherichia coli, a mutation at the strA locus conferred resistance to high levels of the antibiotic. Ozaki et al. (10) were able to correlate this genetic event with an alteration of a specific ribosomal protein. Low level resistance to SM, mapping in loci distinct from strA, has also been described (11) and is assumed to be due to changes in permeability of the cell to the antibiotic. A third mechanism of resistance, carried on transfer factors, involved enzymatic inactivation of the drug by phosphorylation or adenylation (2) .
In Salmonella typhimurium, a locus designated strA that is analogous to the ribosomal alteration in E. coli has been described, as well as strB loci (13) that are genetically distinct from strA. These strB mutants are less resistant than strA to SM, and unlike strA display resistance to a number of other antibiotics. The strB mutants displayed no alteration in ribosomes, protein synthesis, or ability to inactivate SM and are assumed to affect permeability properties of the cell (18) .
In Bacillus subtilis, the only previously described SM-resistant locus is located in a region of the chromosome containing a large number of markers conferring resistance to antibiotics affecting protein synthesis, as well as genes coding for ribosomal ribonucleic acid (RNA) (4) . This mutation is believed to affect the ribosomes, since a change in the migration on gel electrophoresis of a 30S ribosomal component has been observed for one SM-resistant mutant (15) . Recently, Harford and Sueoka (5) described a second locus of spectinomycin resistance mapping at a distance from this previously designated region, but the mechanism of this resistance is unknown.
Our studies of SM resistance in B. subtilis have revealed two further loci conferring resistance to the drug. One locus, which we have called strB, and which may be in the vicinity of spectinomycin resistance described by Harford and Sueoka, results in resistance only during log-phase growth; the organism becomes sensitive to SM during sporulation and germination. The second locus, designated strC, maps in a region enriched in sporulationnegative loci.
MATERIALS AND METHODS Strains. Streptomycin-resistant (SMr) strains were derived by plating either N-methyl-N'-nitro-N'-nitrosoguanidine (NTG)-treated or untreated B. subtilis on plates containing Spizizen's minimal salts (MS) (1), 0.5% glucose, 0.05% casein hydrolysate, and dihydrostreptomycin (DHSM) added to a final concentration of 1 mg/ml. Plates were incubated at 37 C, and resistant colonies were picked and purified. All mutants used in the following experiments were spontaneous mutants with the exception of strBl, which was obtained from NTG- (6) . Auxotrophic markers were selected on plates containing MS, 0.5% glucose, and the required nutrients. Antibiotic-resistant recombinants were detected by replica-plating to appropriately supplemented minimal plates containing 1 mg of DHSM per ml.
Sporulation. Sporulation was studied in a resuspension system modified from that of Sterlini and Mandelstam (16) by the addition of 0.1% glucose to the growth medium. In a typical experiment, cells were grown to an optical density (OD) of 0.2 (660 nm) in the growth medium and harvested by centrifugation. They were washed once in resuspension medium and then resuspended in the same medium to the original OD. Samples were removed at intervals from the resuspension culture, diluted, and plated on Tryptose Blood Agar Base (Difco) to determine viable counts. The number of spores present was determined by shaking the dilutions with a few drops of chloroform prior to plating. All incubations were at 37 C, and DHSM was added as indicated in the individual experiments.
Germination. Spores were obtained by incubating AK plates (Baltimore Biological Labs AK agar no. 3) at 37 C for 4 days. Spores were harvested with sterile water, washed once, and suspended in 10 ml of MS.
Lysozyme was added to 1 mg/ml, and the mixture was incubated for 60 min at 37 C. Sodium lauryl sulfate was added to 0.8%, and incubation was continued for 30 min. Spores were washed twice in sterile water and stored at 4 C. Prior to germination, they were heated at 60 C for 30 min and then suspended in germination medium consisting of 0.5% glucose, 0.025% casein hydrolysate, 0.2% yeast extract, and 0.1 mg of alanine per ml in MS. Cultures were incubated at 37 C on a rotary shaker.
RESULTS
Phenotypic properties of SMr mutants. The SMr mutants described in this study were isolated as resistant to 1 mg of DHSM per ml in a minimal glucose medium. Resistant mutants isolated in this manner differ from the previously described strA mutants in that the latter mutants are resistant to SM in either minimal or enriched media, whereas the present mutants are sensitive to the antibiotic in an enriched medium. Since antibiotic-resistant mutants are normally isolated on enriched media (4), the mutants described here would not be selected in the primary isolation. In minimal media the mutants are resistant to high levels (1 mg/ml) of SM as well as DHSM.
The SMr mutants isolated fell into two groups genetically (see below) and metabolically. One group, strC, was found to be unable to grow on pyruvate, glycerol, or citric acid as sole carbon sources. The second group, strB, was capable of growing on all carbon sources tested. The inability of the strC mutants to grow on the above carbon sources is most likely due to the fact that these mutants lack cytochrome a (H. Taber, personal communication). In this respect, they resemble the multiple aminoglycoside-resistant mutants previously studied (H. Taber, P. Bitoun, and G. Haltenger, Bacteriol. Proc., p. 139, 1970). The strC and strB mutants, however, are not more resistant than the parent strain to neomycin or kanamycin on petri plates of minimal glucose medium containing various levels of these antibiotics. Genetic location of SMr mutations. PBS-1 transducing lysates were prepared on the SMr mutants. These lysates were used to transduce auxotrophic mutations at various locations on the chromosome, and the prototrophs obtained were scored for the introduction of the SMr marker. The cysA14 marker is the closest auxotrophic marker to the ribosomal region (3); strA cotransduces with cysA14 about 70% of the time (3, 5) . No cotransduction of any of the present mutations to cysA14 was observed in over 100 cys+ prototrophs scored. Further twofactor transduction crosses revealed that two mutants, which were previously designated strB, cotransduced with ura-1. Markers on either side of ura-i are metC3 and recAl (7). Although ura-i and metC3 were reported to be linked in PBS-1 transduction (3), we have never been able to show cotransduction of these markers. The strB mutants cotransduced with both ura-i and metC3 (Table 2) so the most likely order of markers in this region is metC3-strB-ura-1-recAI. Since recAI cannot be selected, linkage of strB and recAl could not be tested. This location for strB mutations may be close to that found by Harford and Sueoka (5) for a series of spectinomycin-resistant mutants. These authors did not report a linkage to metC3, however.
The strC mutations were unlinked to either ura-1 or metC3. All of these latter mutations cotransduced about 30% of the time with lys-1 STAAL AND HOCH met+ SMB 110 and aroD4 (Table 3 ). The aroD4 mutation cotransduces weakly (1%) with both Iys-i and phe-i and bridges one of the previous gaps in the chromosome map (Hoch and Nester, manuscript in preparation). On the basis of twofactor crosses, the order of markers is aroD4-strC-lys-1. The area between aroD4 and lys-1 is rich in sporulation markers (8, 12) . From recombination values alone, the strC mutations should be close to the previously described pleiotropic negative spoA locus (6) .
To determine the order of loci in this region, three-factor transduction crosses were performed. A strC6 donor was used to transduce a Iys-1, spoA12 recipient for Iys+, and the segregation of markers among the recombinants was tested. The results of this analysis were consistent with the order strC6-spoA12-1ys-1 (Table 4) . Thus the overall order is most likely aroD4-strC6-spoA12-1ys-1. Although strC and spoA cotransduce with lys-1 and aroD4 at about the same frequency, the two markers are unlinked in transformation analysis. Since the incoming deoxyribonucleic acid (DNA) fragment in transduction is much longer than in transformation (3), this result indicates that the two markers are separated by an amount of genetic material at least equal to the length of the average transforming DNA fragment. The strB and strC designations are used to indicate the location of the markers on the map (Fig. 1 ), but we have no evidence that the mutations within each group are allelic.
Sporulation and SM resistance. One of the most intriguing phenotypes of both strB and strC mutants was the observation that very few spores were seen in cultures growing in the presence of DHSM. This effect of DHSM on sporulation was quantitated by using the resuspension technique of Sterlini and Mandelstam (16) . This technique involves growing the SMs strain in a growth medium to an arbitrary point in log phase, centrifuging the culture, and resuspending the cells in a relatively poor medium (sporulation medium) in which growth stops and massive sporulation occurs about 6 to 8 hr after resuspension. At the time of resuspension, the sporulated fraction of the culture varies from 1 to 10%, and after 9 hr almost complete sporulation is observed. If a culture of either a strB or a strC mutant is transferred to sporulation medium with or without 1 mg of DHSM per ml, the culture without DHSM sporulates quantitatively after 9 hr, whereas the number of spores in the DHSM culture is equal to the number of spores present at the time of resuspension. The same result is obtained with the SM-sensitive parent strain, whereas the number of spores present is unaffected by DHSM in a strA mutant. Thus the strB and strC mutants resemble the sensitive parent strain as far as DHSM and sporulation are concerned.
The differential effect of DHSM on growth and sporulation in the strB and strC mutants led us to ask at what stage in the sporulation process resistance to the antibiotic is lost. This question was investigated in liquid culture by the resuspension technique. Cells were grown up in growth medium to mid-log phase. They were then resuspended in the sporulation medium in which sporulation was essentially complete after 8 hr. During this period there was little if any change in viable count. Logphase cells proved resistant to DHSM as evidenced by the failure of 1 mg of the antibiotic per ml to alter their rate of growth. Appearance of sensitivity to DHSM after resuspension was evaluated by the ability of the cells to form spores after treatment with DHSM. In  Fig. 2 , the results of two experiments are presented. In the first experiment, DHSM was added at the time of resuspension and washed out in separate samples at various times thereafter. The number of spores in each sample was determined 9 hr after resuspension. Removal of DHSM just after resuspension had little effect on the yield of spores. Cells at this time are still DHSM-resistant. With longer incubation in the presence of DHSM, however, there is a rapid decline in the eventual yield of spores. By 3 hr after resuspension, the number of spores found after 9 hr is equal only to the number of spores present as background in the culture at the time of resuspension. Viable cell titer in the presence of DHSM decreased in parallel with the decrease in the ability to sporulate. Resuspension, or the cell changes concomitant with sporulation, leads to a loss of DHSM resistance and to susceptibility of the sporulation process to the antibiotic. To rule out the possibility of a time lag in the effectiveness of the drug, the experiment was repeated employing half-hour pulses of DHSM, which were applied each hour following resuspension of the log-phase culture in sporulation medium. Results by both techniques were identical (Fig. 2) . Thus SM resistance is lost during the early stages of sporulation.
The question arose whether the transition from DHSM resistance to sensitivity was specific to the sporulation process or whether it was simply a consequence of the resuspension technique. This problem was approached by growing the strBl cells to log phase (0.2 OD 660 nm) without DHSM, diluting the culture 1/10 in fresh medium containing 1 mg of DHSM/ml, and allowing growth to reach 0.2 OD, at which time the culture was again diluted 1/10 in the same DHSM-containing medium and grown to 0.2 OD. The spore titer of the original culture at 0.2 OD was 6.4 x 106/ml, the first 1/10 dilution at 0.2 OD was 1.1 x 105/ml, and the second 1/10 dilution at 0.2 OD was 4.7 x 103/ml. Since the DHSM drastically reduces the amount of spontaneous spores found during growth, we conclude that the sensitivity is a consequence of sporulation and not of the , .
In an identical experiment conducted with the strAl strain, DHSM addition had no effect 5 on the growth kinetics even if added at zero time. (Fig. 3) (Fig. 3) . th M ution thuspcon-germination of strBl. Purified spores of strBl were ferswth, reance bothsporDH ionly anduglog-nas suspended in germination medium at time zero, and growth, and both sporulation and germination DHSM was added to a final concentration of 1 are associated with the presence of DHSM mg/ml at the following times: 0 hr (A-A); 1 hr sensitivity.
DISCUSSION
(0 ---0); 2 hr (0-0); 4 hr (A ---A). The genetic linkage of strB mutants to ura-1 is of the same order of magnitude as that found by Harford and Sueoka (5) for spectinomycin-resistant mutants. Smith et al. (13) have suggested that a second set of ribosomal genes is located in this area from data obtained by density-transfer experiments. The location of strC on the chromosome places it among the majority of sporulation-defective mutants that have been analyzed (8, 12) .
The basis for the conditional SMr phenotype of both strB and strC mutations is unknown. Although strC mutants lack cytochrome a, we have no evidence that they are mutant in the structural gene for this cytochrome. The alteration in cytochrome pattern is characteristic of kanamycin-resistant mutants isolated in Staphylococcus aureus (17) and B. subtilis (Taber et al., Bacteriol. Proc., p. 139, 1970). The latter authors have suggested that permeability of the antibiotic is affected by the mutation. The strB mutants show no difference in cytochrome pattern from the wild-type strain. Binding of DHSM to ribosomes in vitro has shown that the strB ribosomes bind the antibiotic to the same extent as wild-type ribosomes. However, the strA ribosomes were also found to bind the antibiotic as well as wildtype ribosomes. Thus our attempts to identify strB mutations were inconclusive. It is possible that the product of the strB locus is involved with either permeability or ribosomal sensitivity, depending upon the physiological state of the cell.
